Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice

Abstract Background New drugs for locally advanced or metastatic breast cancer have led to clinical benefits, aside with increasing costs to healthcare systems. The current financing model for health technology assessment (HTA) privileges real-world data. As part of the ongoing HTA, this study aimed...

Descripció completa

Dades bibliogràfiques

Autors principals:	Filipa Alves da Costa, Fábio Cardoso Borges, Adriana Ramos, Alexandra Mayer, Claudia Brito, Catarina Ramos, Catarina Bernardo, Mariane Cossito, Cláudia Furtado, Arlindo R. Ferreira, Diogo Martins-Branco, Ana da Costa Miranda, António Lourenço
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2023-06-01
Col·lecció:	Breast Cancer Research
Matèries:	Palbociclib Effectiveness Safety Cancer registry
Accés en línia:	https://doi.org/10.1186/s13058-023-01678-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!